Fate Therapeutics, Inc. (FATE)
2.095
+0.06
(+2.70%)
USD |
NASDAQ |
Nov 04, 16:00
2.095
0.00 (0.00%)
After-Hours: 18:52
Fate Therapeutics Total Return Price : 2.095 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 2.04 |
| November 02, 2026 | 2.01 |
| October 30, 2026 | 2.08 |
| October 29, 2026 | 2.17 |
| October 28, 2026 | 2.17 |
| October 27, 2026 | 2.07 |
| October 26, 2026 | 2.055 |
| October 23, 2026 | 2.11 |
| October 22, 2026 | 2.09 |
| October 21, 2026 | 2.07 |
| October 20, 2026 | 2.06 |
| October 19, 2026 | 1.86 |
| October 16, 2026 | 1.79 |
| October 15, 2026 | 1.925 |
| October 14, 2026 | 1.94 |
| October 13, 2026 | 2.00 |
| October 12, 2026 | 2.13 |
| October 09, 2026 | 2.18 |
| October 08, 2026 | 2.13 |
| October 07, 2026 | 2.15 |
| October 06, 2026 | 2.29 |
| October 05, 2026 | 2.43 |
| October 02, 2026 | 2.32 |
| October 01, 2026 | 2.30 |
| September 30, 2026 | 2.37 |
| Date | Value |
|---|---|
| September 29, 2026 | 2.38 |
| September 28, 2026 | 2.38 |
| September 25, 2026 | 2.35 |
| September 24, 2026 | 2.33 |
| September 23, 2026 | 2.43 |
| September 22, 2026 | 2.58 |
| September 21, 2026 | 2.53 |
| September 18, 2026 | 2.53 |
| September 17, 2026 | 2.52 |
| September 16, 2026 | 2.44 |
| September 15, 2026 | 2.35 |
| September 14, 2026 | 2.34 |
| September 11, 2026 | 2.31 |
| September 10, 2026 | 2.33 |
| September 09, 2026 | 2.44 |
| September 08, 2026 | 2.50 |
| September 04, 2026 | 2.48 |
| September 03, 2026 | 2.42 |
| September 02, 2026 | 2.45 |
| September 01, 2026 | 2.43 |
| August 31, 2026 | 2.39 |
| August 28, 2026 | 2.43 |
| August 27, 2026 | 2.54 |
| August 26, 2026 | 2.57 |
| August 25, 2026 | 2.55 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| AVITA Medical, Inc. | 16.31 |
| Agenus, Inc. | 6.985 |
| Amgen, Inc. | 478.34 |
| Anika Therapeutics, Inc. | 20.37 |
| BioCryst Pharmaceuticals, Inc. | 8.26 |